Skip to main content

Table 5 Univariable and multivariable logistic regression on the risk of malaria pigment deposition in the placenta

From: Pregnancy outcomes and risk of placental malaria after artemisinin-based and quinine-based treatment for uncomplicated falciparum malaria in pregnancy: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis

Baseline characteristic

Proportion (%)

Univariable

Multivariable

OR (95% CI)

p value

aOR (95% CI)

p value

Treatment

 AL

733/880 (83%)

Reference

 

Reference

 

 AS

56/84 (67%)

1.63 (0.86–3.10)

0.13

1.77 (0.85–3.68)

0.13

 ASAQ

544/645 (84%)

0.93 (0.67–1.29)

0.68

0.90 (0.63–1.28)

0.55

 ASMQ

560/658 (85%)

0.80 (0.57–1.12)

0.20

0.78 (0.54–1.13)

0.20

 DP

559/642 (87%)

0.96 (0.67–1.36)

0.81

0.91 (0.62–1.34)

0.64

 Q

53/78 (68%)

1.05 (0.55–2.00)

0.89

0.80 (0.38–1.66)

0.55

Interval from malaria to delivery (week)

2505/2987 (84%)

0.98 (0.96–0.99)

0.005

0.97 (0.95–0.99)

0.002

Age (year)

2505/2987 (84%)

0.89 (0.88–0.91)

< 0.001

0.93 (0.91–0.95)

< 0.001

Parity

 0

1199/1292 (93%)

Reference

 

Reference

 

 1

498/580 (86%)

0.50 (0.36–0.69)

< 0.001

0.82 (0.58–1.17)

0.27

 ≥ 2

807/1112 (73%)

0.21 (0.16–0.27)

< 0.001

0.59 (0.41–0.86)

0.006

Weight (kg)

2505/2987 (84%)

0.97 (0.96–0.98)

< 0.001

  

Height (cm)

2383/2806 (85%)

0.98 (0.96–1.00)

0.01

  

BMI (kg/m2)

2383/2806 (85%)

0.95 (0.92–0.99)

0.008

  

HIV infection

 Yes

18/24 (75%)

1.06 (0.40–2.82)

0.91

  

 No

2035/2414 (84%)

Reference

   

Parasitaemia (log10/μL)

2505/2987 (84%)

2.04 (1.76–2.35)

< 0.001

1.67 (1.42–1.96)

< 0.001

Body temperature (°C)

2504/2986 (84%)

1.35 (1.13–1.61)

< 0.001

1.22 (1.00–1.49)

0.045

Haemoglobin (g/dL)

2500/2978 (84%)

0.65 (0.60–0.70)

< 0.001

0.72 (0.65–0.78)

< 0.001

Gametocytaemia

 Yes

84/91 (92%)

3.60 (1.62–7.97)

0.002

3.62 (1.58–8.26)

0.002

 No

2417/2891 (84%)

Reference

 

Reference

 

Mixed infection

 Yes

12/16 (75%)

1.82 (0.57–5.82)

0.31

  

 No

2493/2971 (84%)

Reference

   

Malaria transmission

 Low

159/249 (64%)

1.16 (0.57–2.34)

0.69

0.81 (0.34–1.91)

0.63

 Moderate

1588/1838 (86%)

Reference

 

Reference

 

 High

758/900 (84%)

1.14 (0.66–1.96)

0.65

1.16 (0.63–2.13)

0.64

  1. Intraclass correlation, 0.14. AL artemether-lumefantrine, aOR adjusted odds ratio, AS artesunate monotherapy, ASAQ artesunate-amodiaquine, ASMQ artesunate-mefloquine, BMI body mass index, CI confidence interval, DP dihydroartemisinin-piperaquine, EGA estimated gestational age, G gravidity, HIV human immunodeficiency virus, OR odds ratio, Q quinine monotherapy